Clinical characteristics | Percentage of Patients Attaining Goal | |||
---|---|---|---|---|
N (%) | LDL | HDL | Triglycerides | |
Gender | ||||
Male | 101 (51) | 58.4* | 28.9*** | 74.0 |
Female | 97 (49) | 35.1 | 56.4 | 64.4 |
Marital Status | ||||
Married | 112 (76) | 50.0*** | 37.6 | 66.4 |
Unmarried | 36 (24) | 41.9 | 47.8 | 72.2 |
Race/ethnicity | ||||
Black | 23 (12) | 34.8 | 75.0** | 83.3 |
Hispanic | 20 (10) | 35.0 | 35.0 | 55.0 |
Other | 22 (11) | 50.0 | 37.5 | 82.6 |
White | 133 (67) | 50.4 | 38.1 | 66.2 |
Insurance | ||||
Private fee-for-service | 82 (41) | 51.2 | 37.7 | 62.4 |
Private, HMO | 39 (20) | 41.0 | 41.9 | 61.9 |
Medicare + supplemental | 23 (12) | 34.8 | 56.6 | 91.3 |
Medicare alone | 45 (23) | 51.0 | 43.5 | 76.1 |
Other | 9 (4) | 44.4 | 40.0 | 70.0 |
Smoking status | ||||
Nonsmoker | 180 (95) | 46.7 | 42.6 | 69.5 |
Smoker | 9 (5) | 0.0 | 36.8 | 63.2 |
Education | ||||
Less than high school | 52 (26) | 36.5 | 40.7* | 64.8 |
High school graduate | 67 (34) | 49.3 | 54.9 | 71.4 |
Post high school | 79 (40) | 51.9 | 31.7 | 69.5 |
Patient received patient education | ||||
Yes | 127 (64) | 46.5 | 42.1 | 68.4 |
No | 71 (36) | 47.9 | 41.9 | 69.9 |
Patient taking ACE inhibitor or receptor blocker | ||||
Yes | 100 (51) | 53.0 | 38.6 | 73.3 |
No | 98 (49) | 40.8 | 45.3 | 64.8 |
Patients taking lipid-lowering drug | ||||
Yes | 81 (41) | 65.4*** | 34.9 | 63.5 |
No | 117 (59) | 35.0 | 47.1 | 72.7 |
Patients taking sulfonylurea | ||||
Yes | 73 (37) | 46.6 | 43.6 | 65.4 |
No | 125 (63) | 47.2 | 41.1 | 71.1 |
Patients taking metformin | ||||
Yes | 109 (55) | 48.6 | 38.1 | 63.7 |
No | 89 (45) | 44.9 | 46.8 | 75.3 |
Patients on insulin therapy | ||||
Yes | 25 (13) | 32.0 | 46.2 | 61.5 |
No | 173 (87) | 49.1 | 41.4 | 70.0 |
Patients on a thiazolidinedione | ||||
Yes | 34 (17) | 58.8 | 48.6 | 71.4 |
No | 164 (83) | 44.5 | 40.7 | 68.4 |
ACE, angiotensin-converting enzyme inhibitor.
* P < .05
** P < .01
*** P < .001